Equities
  • Price (EUR)1.16
  • Today's Change-0.01 / -0.86%
  • Shares traded0.00
  • 1 Year change-54.41%
  • Beta--
Data delayed at least 15 minutes, as of Apr 29 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Agfa Gevaert NV is a Belgium-based company that develops, produces and distributes analog and digital imaging systems and information technology (IT) solutions, mainly for the printing industry and the healthcare sector, as well as for specific industrial applications. The Company’s activities are divided into three independent business groups: Agfa Graphics, its dominant segment, which offers integrated pre-press solutions to the printing industry; Agfa HealthCare, which supplies hospitals and other healthcare centers with systems for capturing, processing and managing diagnostic images; and Agfa Specialty Products, which supplies a film-based products and high-tech solutions to business-to-business customers outside the graphic and healthcare markets. The Company is active worldwide through more than 40 wholly-owned sales organizations and runs manufacturing sites in Argentina, Brazil, China, France, Germany, Italy, Japan, South Korea, Taiwan the United Kingdom and the United States.

  • Revenue in EUR (TTM)1.15bn
  • Net income in EUR-53.00m
  • Incorporated1964
  • Employees5.03k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.